Effects of Atrial Fibrillation and Chronic Kidney Disease on Major Adverse Cardiovascular Events

Wern Yew Ding; Professor Gregory Lip; Daniele Pastori; Alena Shantsila

doi:10.1016/j.amjcard.2020.07.004

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2018

Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

Valeria Raparelli, Daniele Pastori, Serena Francesca Pignataro, Anna Rita Vestri, Pasquale Pignatelli, Roberto Cangemi, Marco Proietti, Giovanni Davı̀, William R. Hiatt, Professor Gregory Lip, Gino Roberto Corazza, Francesco Perticone, Francesco Violi, Stefania Basili

Article2020

Pathophysiology of atrial fibrillation and chronic kidney disease

Wern Yew Ding, Dhiraj Gupta, Christopher F. Wong, Professor Gregory Lip

Article2021

Atrial Fibrillation in Patients with Chronic Kidney Disease

Agnieszka Kotalczyk, Wern Yew Ding, Christopher F. Wong, Anirudh Rao, Dhiraj Gupta, Professor Gregory Lip

Article2023

Risk of major cardiovascular events and bleeding in atrial fibrillation patients with chronic obstructive pulmonary disease treated with low dose azithromycin prophylaxis

Tommaso Bucci, Freddy Frost, D Wat, Sarah Sibley, Pasquale Pignatelli, Daniel J. Green, Professor Gregory Lip

Article2025

Cerebral Small Vessel Disease and Major Adverse Cardiovascular Events: The Framingham Heart Study (S30.002)

Ranjit Manchanda, Adlin Pinheiro, Hugo J. Aparicio, Vasileios‐Arsenios Lioutas, Alexa Beiser, Oluchi Ekenze, Emelia Benjamin, Charles DeCarli, Sudha Seshadri, Serkalem Demissie, José R. Romero